Springer Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer

Product Description This volume reviews the evolution of information regarding the epidemiology of DCIS and its modes of detection, as well as treatment options as a function of both clinical trial data and ongoing investigational therapeutic prospects. Several of the challenging and clinically-relevant scenarios of DCIS that appear in daily practice is discussed, including the difficulties of distinguishing “true” DCIS from borderline patterns of other breast diseases and the therapeutic implications of differentiating these various diagnoses. Particular attention is paid to pathologic evaluation of DCIS, including histologic patterns and the importance of margin evaluation/margin control. The text also explores the data regarding DCIS in medical research in hereditary susceptibility for breast cancer and race/ethnicity-associated disparities in breast cancer. Written by experts in the field, Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer. Review “This is a slim but meaty monograph on ductal carcinoma in situ (DCIS) and microinvasive breast cancer. ... The book is appropriately illustrated with mammograms and pathology examples and is heavily referenced. ... This is really most appropriate for specialists (medical and surgical oncologists) and specialty trainees. ... Trainees in these specialties will find it an excellent, balanced review of particularly thorny issues.” (Carol Scott-Conner, Doody's Book Reviews, September, 2016) From the Back Cover This volume reviews the  evolution of information regarding the epidemiology of DCIS and its modes of detection, as well  as treatment options as a function of both clinical trial data and ongoing investigational therapeutic prospects. Several of the challenging and clinically-relevant scenarios of DCIS that appear in daily practice is discussed, including the difficulties of distinguishing “true” DCIS from borderline patterns of other breast diseases and the therapeutic implications of differentiating these various diagnoses. Particular attention is paid to pathologic evaluation of DCIS, including histologic patterns and the importance of margin evaluation/margin control. The text also explores the data regarding DCIS in medical research in hereditary susceptibility for breast cancer and race/ethnicity-associated disparities in breast cancer. Written by experts in the field, Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer. About the Author Lisa A. Newman, MD, MPH, FACSProfessor of Surgery, Director, Breast Care Center, University of Michigan Health System, Comprehensive Cancer Center, Ann Arbor, MI, USA Jessica M. Bensenhaver, MDAssistant Professor of Surgery, University of Michigan Health System, Comprehensive Cancer Center, Ann Arbor, MI, USA